Gesynta Pharma has dosed the first patient in its Phase II trial, NOVA, investigating vipoglanstat, a non-hormonal, ...

Whether happening in public or private, biopharma M&A is fiercer than ever. Experts point to patent pressures, herd mentality ...

Eli Lilly is making investments in China, Japan and South Korea. Pfizer has broken into obesity thanks to a Chinese nod won by its local partner Sciwind Biosciences. | Eli Lilly is making investments ...

Rapid Micro Biosystems, Inc. sees strong FY25 revenue growth from Growth Direct placements, but losses persist. Click for ...

BridgeBio Pharma Inc. BBIO on Wednesday announced a recent presentation of interim results from its Phase 3 FORTIFY trial for BBP-418, a treatment for limb-girdle muscular dystrophy type 2I/R9.

Health officials dial down vaccine criticism; Astellas Pharma benefits from Trump’s drug pricing push; Eli Lilly eyes permanent stay at $1T club.

The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a time when the U.S. is distancing from China.

How telehealth companies prescribe GLP-1 drugs; Have compounding pharmacies won?; Lilly warns against impurities in compounded versions of Mounjaro.

Shares of Japan's Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

UVeCARE earned major recognition at the Natural Health Readers' Choice Awards 2025, winning the prestigious Natural ...

For two decades, the branded pharma website has been treated as the centerpiece of digital engagement. It has been the polished ‘front door’, where brands prepared to tell their story and hoped ...